Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response

Luigi Maria Larocca, Luca Laurenti, Idanna Innocenti, Francesco Autore, Martina Iezzi, Mirco Di Marco, Serena Veschi, Paola Lanuti, Alice Ramassone, Stefania Pacillo, Sara Pagotto, Felice Pepe, Jonahunnatha Nesson George-William, Claudia Curcio, Marco Marchisio, Sebastiano Miscia, Patrizia Di Gregorio, Mario Di Gioacchino, Silvia Valentinuzzi, Manuela IezziRenato Mariani-Costantini, Angelo Veronese, Rosa Visone

Risultato della ricerca: Contributo in rivistaArticolo in rivista


The clinical progression of B cell chronic lymphocytic leukemia (CLL) is associated with immune cell dysfunction and a strong decrease of miR-181b-5p (miR-181b), promoting the death of CLL cells. Here we investigated whether the reduction of miR-181b impairs the immune response in CLL. We demonstrate that activated CD4+ T cells increase miR-181b expression in CLL through CD40– CD40L signaling, which enhances the maturation and activity of cytotoxic T cells and, consequently, the apoptotic response of CLL cells. The cytotoxic response is facilitated by a depletion of the anti-inflammatory cytokine interleukin 10, targeted by miR-181b. In vivo experiments in NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice confirmed that miR-181b promotes the apoptotic death of CLL cells only when functional T cells are restored. Overall, our findings suggest that the reinstatement of miR-181b in CLL cells could be an exploitable adjuvant therapeutic option for the treatment of CLL.
Lingua originaleEnglish
pagine (da-a)1-20
Numero di pagine20
Stato di pubblicazionePubblicato - 2021


  • CD40-CD40L
  • CLL
  • MiR-181b
  • MicroRNA
  • Cytotoxic T cells


Entra nei temi di ricerca di 'Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response'. Insieme formano una fingerprint unica.

Cita questo